EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Salvianolic Acid A Mitigates Osteoporotic Bone Loss by Repressing Reactive Oxygen Species via the Nrf2–HO‐1 Pathway

Hao Qiu iD, Chenhui Cai, Ying Zhang, Sizhen Yang, Xu Hu, Tongwei Chu

Phytotherapy Research · 2025

DOI: 10.1002/ptr.8503 ↗

At a glance

Journal article in Phytotherapy Research, 2025. Written by Hao Qiu and 5 co-authors. Institution: Department of Orthopedics, Xinqiao Hospital, Army Medical University, Chongqing, China. Major MEDLINE topics: NF-E2-Related Factor 2, Reactive Oxygen Species, Osteoporosis, Caffeic Acids. Cited 8 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY 4.0). Funded by: the Clinical Research Project of the Second Affiliated Hospital of Army Medical University, the Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Osteoporosis, characterized by osteoclastic bone resorption, has been the focus of research. Studies implicate that reactive oxygen species (ROS) accumulate intracellularly during osteoclastogenesis. Salvianolic acid A (SAA), a compound derived from Salvia miltiorrhiza , has been widely used to treat cardiovascular and cerebrovascular disorders, owing to its antioxidant and anti‐inflammatory properties. In this study, we investigated the therapeutic effects of SAA on osteoporotic bone loss in vitro and in osteoporotic mice induced by ovariectomy (OVX) and explored the underpinning mechanisms. In vitro, SAA significantly restrained osteoclastogenesis and osteoclastic resorption in a dose‐ and time‐dependent manner. SAA markedly blocked the expression of osteoclast‐specific genes and proteins such as NFATc1 and c‐Fos. Specifically, SAA reduced ROS production by enhancing the expression and nuclear translocation of nuclear factor erythroid 2‐related factor 2 (Nrf2) to activate HO‐1 and catalase, with no effect on Bach1. In addition, SAA simultaneously suppressed the NF‐κB and mitogen‐activated protein kinase (MAPK) signaling pathway, ultimately arresting NFATc1 expression to constrain the differentiation and function of osteoclasts. Micro‐CT and histological evidence demonstrated that SAA at a nontoxic dose successfully reduced bone loss induced by OVX, with fewer mature osteoclasts. These findings revealed that SAA provides a potential treatment strategy for reducing osteoclast‐related bone ailments, including osteoporosis.

Subjects

MeSH terms (MEDLINE)

NF-E2-Related Factor 2Reactive Oxygen SpeciesOsteoporosisCaffeic AcidsLactatesAnimalsMiceOsteoclastsFemaleNFATC Transcription FactorsOvariectomySignal TransductionMice, Inbred C57BLHeme Oxygenase-1OsteogenesisBone ResorptionNF-kappa BRAW 264.7 CellsMembrane Proteins

Author keywords

NFATc1NRF2OsteoclastROSSAA

Substances

NF-E2-Related Factor 2Reactive Oxygen SpeciesNfe2l2 protein, mousesalvianolic acid ACaffeic AcidsLactatesNFATC Transcription FactorsHeme Oxygenase-1Hmox1 protein, mouseNF-kappa B

Authors and institutions

  • Department of Orthopedics, Xinqiao Hospital, Army Medical University, Chongqing, China.

ORCID profiles: Hao Qiu

Funding

  • the Clinical Research Project of the Second Affiliated Hospital of Army Medical University
  • the Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission

Cite

APA

Qiu, H., Cai, C., Zhang, Y., Yang, S., Hu, X., & Chu, T. (2025). Salvianolic Acid A Mitigates Osteoporotic Bone Loss by Repressing Reactive Oxygen Species via the Nrf2–HO‐1 Pathway. Phytotherapy Research. https://doi.org/10.1002/ptr.8503

Vancouver

Qiu H, Cai C, Zhang Y, Yang S, Hu X, Chu T. Salvianolic Acid A Mitigates Osteoporotic Bone Loss by Repressing Reactive Oxygen Species via the Nrf2–HO‐1 Pathway. Phytotherapy Research. 2025. doi:10.1002/ptr.8503

BibTeX
@article{Qiu2025,
  author = {Qiu, Hao and Cai, Chenhui and Zhang, Ying and Yang, Sizhen and Hu, Xu and Chu, Tongwei},
  title = {Salvianolic Acid A Mitigates Osteoporotic Bone Loss by Repressing Reactive Oxygen Species via the Nrf2–HO‐1 Pathway},
  journal = {Phytotherapy Research},
  year = {2025},
  doi = {10.1002/ptr.8503}
}
Start for free →